A Certificate of Analysis (COA) for CJC-1295 and Ipamorelin provides verifiable quantitative documentation confirming molecular identity, chemical purity, and microbiological safety thresholds. Evaluating raw analytical data ensures that research reagents meet rigid ISO 17025 standards for preclinical cellular and animal models.
A Certificate of Analysis (COA) for CJC-1295 and Ipamorelin provides verifiable quantitative documentation confirming molecular identity, chemical purity, and microbiological safety thresholds. Evaluating raw analytical data ensures that research reagents meet rigid ISO 17025 standards for preclinical cellular and animal models.
A CJC-1295 Ipamorelin COA is an official analytical document issued by an independent ISO 17025-accredited testing facility verifying the identity, chemical purity, and biological safety of a specific peptide synthesis lot. It details exact quantitative values derived from Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC), Liquid Chromatography-Mass Spectrometry (LC-MS), and bacterial endotoxin testing.
When procurement specialists and bench scientists evaluate research compounds, examining an authentic Certificate of Analysis (COA) is the primary line of defense against batch variability, degradation products, or synthetic impurities. In preclinical investigations studying pituitary signaling or somatotroph axis dynamics, using fully verified reagents is crucial for maintaining experimental control. Accessing full analytical documentation across our entire catalog of research peptides allows principal investigators to validate structural integrity prior to initiating in vitro or animal models.
A rigorous Certificate of Analysis goes far beyond a simple pass/fail designation. It outlines several quantitative metrics that define peptide stability, concentration accuracy, and baseline purity. When reviewing documentation for a dual-peptide preparation such as a CJC-1295 Ipamorelin blend, researchers must verify that each constituent peptide has been individually identified and measured against validated reference standards.
Key metrics on a standardized COA include chromatographic purity (expressed as a percentage of total peak area), mass-to-charge ratio ($m/z$), total peptide content, net peptide weight, residual counter-ion percentage (typically trifluoroacetate or acetate), and endotoxin concentration measured in Endotoxin Units per milligram (EU/mg). Understanding these baseline analytical parameters ensures that cellular assays are free from confounding chemical or biological artifacts.
Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) is the gold standard method for determining the chemical purity of synthetic peptides. The technique separates molecules based on hydrophobic interactions between the peptide analyte and a stationary phase column, eluted via a non-polar organic solvent gradient (typically acetonitrile with 0.1% trifluoroacetic acid).
A compliant RP-HPLC chromatogram displays a prominent, sharp main peak corresponding to the target peptide, with secondary peaks indicating minor truncated sequences, oxidation products, or side-chain protecting group remnants. For laboratory-grade peptides, total integrated peak area for the target molecule must meet or exceed 98.0%. When reviewing COA documentation for CJC-1295 No DAC, clean baseline separation confirms that the synthesis protocol successfully avoided deletion sequences common in solid-phase peptide synthesis (SPPS).
While RP-HPLC measures relative purity, Mass Spectrometry (MS) verifies structural identity by measuring the exact molecular weight of the peptide. Electrospray Ionization Mass Spectrometry (ESI-MS) or Matrix-Assisted Laser Desorption/Ionization (MALDI-TOF) ionizes the compound to determine its mass-to-charge ratio ($m/z$).
The observed monoisotopic or average molecular mass on the COA must match the theoretical molecular weight calculated from the amino acid sequence within a strict tolerance window (typically $\pm 1$ Da). For instance, verifying single-peptide lots such as pure Ipamorelin requires LC-MS spectrum data demonstrating a primary peak at the exact expected mass of 711.86 Da. Any significant variance in observed mass indicates potential structural modifications, amino acid substitutions, or sample degradation.
Bacterial endotoxins—lipopolysaccharides (LPS) derived from the outer cell wall of Gram-negative bacteria—are potent pyrogens that can induce severe inflammatory responses in biological systems. Even trace endotoxin contamination can skew cell culture viability assays, trigger immune signaling cascades, and invalidate cytokine response studies in animal models.
A high-grade peptide COA must detail quantitative endotoxin levels assessed via the Chromogenic Limulus Amebocyte Lysate (LAL) assay or Recombinant Factor C (rFC) assay. For rigorous preclinical research, endotoxin concentrations should consistently test below 0.05 EU/mg. PX1 Research subjects every batch to stringent screening protocols within our research library hub, ensuring that reagents do not introduce exogenously driven inflammatory artifacts into sensitive receptor assays.
CJC-1295 is studied as a synthetic peptide derivative of growth hormone-releasing hormone (GHRH), specifically optimized as a 29-amino-acid modified growth-hormone-releasing factor analog. In preclinical models, GHRH analogs act directly on the growth-hormone-releasing hormone receptor (GHRHR) located on anterior pituitary somatotroph cells. Binding to GHRHR activates the adenylate cyclase-cAMP-protein kinase A pathway, stimulating the transcription and release of endogenous growth hormone (GH).
As a modified GHRH analog, CJC-1295 is studied as a long-acting growth-hormone-releasing hormone that sustains GH and downstream insulin-like growth factor 1 (IGF-1) levels for tissue repair research. In rodent and in vitro models, the structural alterations—specifically substitution of D-alanine, glutamine, alanine, and leucine residues—confer resistance to cleavage by dipeptidyl peptidase-4 (DPP-4), significantly extending its half-life relative to native GHRH(1-29).
Ipamorelin is a synthetic pentapeptide (Aib-His-D-2-Nal-D-Phe-Lys-NH2) classified as a selective growth hormone secretagogue and ghrelin receptor agonist. Unlike systemic GHRH analogs, Ipamorelin binds specifically to the growth hormone secretagogue receptor 1a (GHSR-1a) on pituitary somatotrophs.
Preclinical studies indicate that Ipamorelin induces GH secretion through intracellular calcium mobilization without altering secondary hormonal pathways. In vitro pituitary cell cultures demonstrate that Ipamorelin does not trigger significant release of cortisol, adrenocorticotropic hormone (ACTH), prolactin, or aldosterone, making it an exceptionally clean molecular tool for isolating secretagogue-mediated pathways in somatotrophic axis research.
Combining a GHRH analog with a selective GHRP/GHSR agonist models a dual-receptor stimulation strategy in neuroendocrine research. In vitro and animal studies demonstrate that simultaneous activation of GHRHR (via CJC-1295) and GHSR-1a (via Ipamorelin) produces a synergistic, amplification effect on growth hormone pulse amplitude that exceeds the additive effects of either peptide administered independently.
This dual-action approach is widely utilized in laboratory setups exploring baseline pituitary reserve capacity, musculoskeletal extracellular matrix synthesis, and local IGF-1 upregulation. Reviewing a combined batch COA ensures that both peptides are present at exact stoichiometric ratios, free of cross-reactive synthesis fragments that could interfere with dual-receptor binding kinetics.
Within neuroendocrine research, growth hormone secretagogues are generally grouped into GHRH receptor agonists or ghrelin receptor (GHSR-1a) agonists. For instance, CJC-1295 No DAC provides short-duration GHRH receptor binding, whereas extended analogs like Tesamorelin feature a hexenoyl moiety that alters lipid metabolic pathways in specific preclinical models. Conversely, Sermorelin represents the truncated 29-amino-acid sequence of native GHRH, exhibiting rapid enzymatic clearance compared to modified analogs. Comparing these mechanisms alongside selective GHRPs like Ipamorelin allows investigators to select precise ligand kinetics for targeted cell signaling studies.
To review comparative analytical profiles, molecular weights, and reference standards across these classes, researchers can explore our complete directory of GHRH analogs and related secretagogue research articles.
To maintain the analytical specifications confirmed on a COA, proper laboratory handling of lyophilizates is mandatory. Lyophilized peptide vials should be stored at -20°C to -80°C in a desiccated environment to prevent atmospheric moisture absorption and hydrolytic degradation.
Reconstitution should be performed using sterile Bacteriostatic Water (0.9% benzyl alcohol) or sterile normal saline (0.9% NaCl), depending on assay compatibility. Solvent should be introduced slowly down the internal glass wall of the vial, followed by gentle swirling—never vigorous vortexing, which can denature delicate peptide tertiary structures. Post-reconstitution, liquid aliquots should be refrigerated at 2°C to 8°C and evaluated within established stability windows. Bulk research laboratories requiring standardized lot volumes can access dedicated fulfillment terms through a PX1 wholesale account.
PX1 Research enforces stringent quality control measures to guarantee that every compound matches its published COA down to the part-per-million. All peptides are synthesized in state-of-the-art, GMP-compliant facilities within the United States, utilizing automated solid-phase peptide synthesis (SPPS) platforms.
Independent verification is performed by accredited ISO 17025 testing facilities using validated RP-HPLC, LC-MS, and LAL assays. Every shipped lot is linked to a downloadable COA featuring raw chromatograms, accurate mass spectra, and traceable lot numbers. Combined with same-day dispatch from our California and Arizona fulfillment centers (Monday through Friday), PX1 Research provides primary research institutions with uncompromised reagent purity and supply chain reliability.
What exact testing methods are shown on a CJC-1295 Ipamorelin COA?
A comprehensive COA includes Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) for chromatographic purity, Liquid Chromatography-Mass Spectrometry (LC-MS) for mass identification, and Chromogenic LAL testing for bacterial endotoxins.
What is the minimum purity standard for PX1 Research CJC-1295 Ipamorelin?
PX1 Research requires a minimum RP-HPLC purity of 98.0% for all research peptides, with exact lot purity percentages documented on each Certificate of Analysis.
What is the difference between CJC-1295 with DAC and CJC-1295 No DAC on a COA?
CJC-1295 with DAC (Drug Affinity Complex) contains a Lys(Maleimidopropionyl) modification that alters its molecular weight (theoretical MW approx 3647.2 Da) compared to CJC-1295 No DAC (Modified GRF 1-29, theoretical MW approx 3367.9 Da). The COA mass spec section clearly distinguishes between these structures based on observed mass.
How is endotoxin content measured and reported on the COA?
Endotoxin levels are quantified in Endotoxin Units per milligram (EU/mg) using an LAL assay. Premium laboratory-grade compounds maintain endotoxin levels below 0.05 EU/mg to avoid inflammatory interference in cellular models.
Why does net peptide weight differ from total lyophilized powder weight?
Lyophilized cakes contain the active peptide alongside trace moisture and counter-ions (such as acetate or trifluoroacetate) resulting from the purification process. The COA reports true peptide purity and net peptide content to allow precise molar reconstitution.
Where are PX1 Research CJC-1295 and Ipamorelin peptides manufactured?
All PX1 Research peptides are manufactured in US-based GMP-compliant synthesis facilities and independently tested by accredited ISO 17025 laboratories.
How should reconstituted CJC-1295 and Ipamorelin be stored in the lab?
Once reconstituted with sterile bacteriostatic water, vials should be stored at 2°C to 8°C and protected from light. For extended storage, freeze reconstituted aliquots at -20°C or -80°C to minimize freeze-thaw degradation cycles.
How can I access the COA for my specific batch of CJC-1295 Ipamorelin?
Every product shipped by PX1 Research includes a batch-specific lot number. PIs and laboratory managers can enter this lot number on our site or scan the vial QR code to view and download full raw HPLC and MS analytical reports.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.